Works matching IS 20401116 AND DT 2023 AND VI 14 AND IP 3


Results: 19
    1
    2
    3
    4
    5
    6
    7
    8
    9

    Empagliflozin is associated with lower risk of cardiovascular events and all‐cause mortality in routine care in East Asia: Results from the EMPRISE study.

    Published in:
    Journal of Diabetes Investigation, 2023, v. 14, n. 3, p. 417, doi. 10.1111/jdi.13959
    By:
    • Kim, Dae Jung;
    • Sheu, Wayne H‐H;
    • Chung, Wook‐Jin;
    • Yabe, Daisuke;
    • Ha, Kyoung Hwa;
    • Nangaku, Masaomi;
    • Tan, Elise Chia‐Hui;
    • Node, Koichi;
    • Yasui, Atsutaka;
    • Lei, Weiyu;
    • Lee, Sunwoo;
    • Saarelainen, Laura;
    • Deruaz‐Luyet, Anouk;
    • Kyaw, Moe H;
    • Seino, Yutaka
    Publication type:
    Article
    10

    Association of cardiovascular health metrics with annual incidence of prediabetes or diabetes: Analysis of a nationwide real‐world database.

    Published in:
    Journal of Diabetes Investigation, 2023, v. 14, n. 3, p. 452, doi. 10.1111/jdi.13958
    By:
    • Okada, Akira;
    • Kaneko, Hidehiro;
    • Matsuoka, Satoshi;
    • Itoh, Hidetaka;
    • Suzuki, Yuta;
    • Fujiu, Katsuhito;
    • Michihata, Nobuaki;
    • Jo, Taisuke;
    • Takeda, Norifumi;
    • Morita, Hiroyuki;
    • Yamaguchi, Satoko;
    • Node, Koichi;
    • Yamauchi, Toshimasa;
    • Yasunaga, Hideo;
    • Komuro, Issei
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19

    Issue Information.

    Published in:
    Journal of Diabetes Investigation, 2023, v. 14, n. 3, p. i, doi. 10.1111/jdi.13847
    Publication type:
    Article